Medical Marijuana, Inc.'s Video Statement on Investment Portfolio's Historic Accomplishments and Supporting the Science Behind Cannabis Legalization
15 juil. 2015 10h15 HE
|
Medical Marijuana Inc
SAN DIEGO, July 15, 2015 (GLOBE NEWSWIRE) -- "Honestly, if you and I would have sat here two or three years ago, people would be saying, 'I would never invest in marijuana stocks,'" states Andrew...
Medical Marijuana, Inc.'s HempMeds Participates in New York Cannabis World Congress & Business Expo
12 juin 2015 10h28 HE
|
Medical Marijuana Inc
SAN DIEGO, June 12, 2015 (GLOBE NEWSWIRE) -- The entrepreneurial spirit is thriving in New York. As the state prepares for medical cannabis availability, cultivation and dispensary licenses are...
National News Coverage for KannaLife Sciences, Inc. an MJNA Portfolio Company
02 déc. 2014 09h00 HE
|
Medical Marijuana Inc
SAN DIEGO, Dec. 2, 2014 (GLOBE NEWSWIRE) -- News of a potential NFL lawsuit settlement and KannaLife Sciences, Inc. ("KannaLife") license from National Institutes of Health – Office of...
Medical Marijuana, Inc. Portfolio Company KannaLife Sciences Covered by International Press for Signing New License With NIH to Develop Treatment for CTE Using Medicinal Marijuana
20 août 2014 09h09 HE
|
Medical Marijuana Inc
SAN DIEGO, Aug. 20, 2014 (GLOBE NEWSWIRE) -- From the US to Turkey, the world is "buzzing" with the news that the National Institutes of Health, a U.S. Government Agency division of the Department of...
National Press Coverage for Medical Marijuana, Inc. -- Portfolio Company Kannalife Sciences Awarded NIH License to Develop Target Drugs to Treat Concussion Syndrome CTE Using Marijuana
05 août 2014 14h45 HE
|
Medical Marijuana Inc
SAN DIEGO, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce that one of its investment portfolio companies, KannaLife Sciences, Inc. ("KannaLife"), a...
DiamiR Granted Key US Patent for the Use of Circulating Brain-Enriched microRNAs for Early Detection of Neurodegeneration
12 févr. 2014 06h02 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - February 12, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...